---
title: "EZZ Life Science Reports Lapse of Conditional Securities"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/271159105.md"
description: "EZZ Life Science Holdings Ltd. (AU:EZZ) has announced the lapse of 10,000 performance rights and 130,000 ordinary shares due to unmet conditions, reducing potential future dilution. This change does not affect the company's core operations but indicates that certain performance hurdles were not achieved. The latest analyst rating for EZZ stock is a Hold with a price target of A$1.50. EZZ operates in the health and wellness sector and has a market cap of A$65.57M."
datetime: "2025-12-31T01:38:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271159105.md)
  - [en](https://longbridge.com/en/news/271159105.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271159105.md)
---

# EZZ Life Science Reports Lapse of Conditional Securities

### Claim 70% Off TipRanks This Holiday Season

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) just unveiled an update.

EZZ Life Science Holdings has notified the market of the cessation of several classes of securities, with 10,000 performance rights and a total of 130,000 ordinary fully paid shares lapsing after the conditions attached to those securities were not met or became incapable of being satisfied between October 2025 and early January 2026. The lapses reduce potential future dilution from these conditional equity instruments and slightly adjust the company’s issued capital profile, but do not reflect any change in its core operations, instead signalling that certain performance or vesting hurdles tied to those securities were not achieved.

The most recent analyst rating on (AU:EZZ) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.

**More about EZZ Life Science Holdings Ltd.**

EZZ Life Science Holdings Limited is an Australia-listed life sciences company (ASX: EZZ) operating in the health and wellness sector, with its capital structure including ordinary fully paid shares and performance rights traded on the ASX.

**Average Trading Volume:** 70,781

**Technical Sentiment Signal:** Sell

**Current Market Cap:** A$65.57M

See more insights into EZZ stock on TipRanks’ Stock Analysis page.

## Related News & Research

- [Bell Potter Sticks to Their Buy Rating for WA1 Resources Ltd (WA1)](https://longbridge.com/en/news/286490349.md)
- [Bell Potter Sticks to Their Buy Rating for Minerals 260 Limited (MI6)](https://longbridge.com/en/news/286539316.md)
- [Challenger  (CFIGF) Gets a Buy from Ord Minnett](https://longbridge.com/en/news/286831053.md)
- [Shaw and Partners Reaffirms Their Buy Rating on Wisr Ltd. (WZR)](https://longbridge.com/en/news/286688085.md)
- [Insider Buyers Lose AU$108k As Jupiter Energy Sheds AU$5.0m](https://longbridge.com/en/news/286002476.md)